Current systemic treatment options and new developments in palliative first-line treatment of head and neck squamous cell carcinoma

被引：1

作者：

Kocher, Florian ^{[1
]}

Seeber, Andreas ^{[1
]}

机构：

[1] Med Univ Innsbruck, Comprehens Canc Ctr Innsbruck, Dept Internal Med Hematol & Oncol 5, Anichstr 35, A-6020 Innsbruck, Austria

来源：

MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2023年 / 16卷 / 03期

关键词：

Head and neck squamous cell carcinoma (HNSCC); Palliative first-line tratment; Recent trials; Treatment algorithm; OPEN-LABEL; PLUS PACLITAXEL; METASTATIC HEAD; PEMBROLIZUMAB; CETUXIMAB; CHEMOTHERAPY; RECURRENT; FLUOROURACIL; KEYNOTE-048; MULTICENTER;

D O I：

10.1007/s12254-023-00901-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This short review gives an overview of current treatment concepts, recently published trials, and novel developments in relapsed or metastatic head and neck squamous cell carcinoma (HNSCC) not amendable for local curative treatment. Trials with potential future clinical implications and relevant updates of landmark trials are provided as well.

引用

页码：176 / 179

页数：4

共 50 条

[41] Protein-Based Oncopanel as Addition to Target Sequencing in Head and Neck Squamous Cell Carcinoma to Individualize Treatment Decisions
von Witzleben, Adrian
Mueller-Richter, Urs
Maurus, Katja
Braendlein, Stephanie
Theodoraki, Marie-Nicole
Brunner, Cornelia
Laban, Simon
Lennerz, Jochen
Moeller, Peter
Hoffmann, Thomas K.
Doescher, Johannes
Schuler, Patrick J.
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
[42] PD-1/PD-L1 inhibitor plus chemotherapy versus standard of care in the first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma
Mo, Dun-Chang
Huang, Jian-Feng
Luo, Peng-Hui
Chen, Long
Zou, Biao
Wang, Han-Lei
[J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2023, 280 (01) : 1 - 9
[43] Palliative treatment standards for head and neck squamous cell carcinoma. Survey of clinical routine in German-speaking countries
Laban, S.
Kimmeyer, J.
Knecht, R.
Hoffmann, T. K.
Busch, C. -J.
Veit, J. A.
Moeckelmann, N.
Kurzweg, T.
[J]. HNO, 2016, 64 (07) : 487 - 493
[44] Real-world systemic therapy treatment patterns for squamous cell carcinoma of the head and neck in Canada
Byrne, K.
Hallworth, P.
Monfared, A. Abbas Tahami
Moshyk, A.
Shaw, J. W.
[J]. CURRENT ONCOLOGY, 2019, 26 (02) : E167 - E174
[45] Pembrolizumab for the treatment of head and neck squamous cell cancer
Ho, Won Jin
Mehra, Ranee
[J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (09) : 879 - 885
[46] Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
Argiris, Athanassios
Harrington, Kevin J.
Tahara, Makoto
Schulten, Jeltje
Chomette, Pauline
Castro, Ana Ferreira
Licitra, Lisa
[J]. FRONTIERS IN ONCOLOGY, 2017, 7
[47] Established treatment concepts for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSSC)
Kloppenburg, Marcel
Mildner, Finn
Kasseroler, Maria Theresia
Dejaco, Daniel
Amann, Arno
[J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (04) : 395 - 399
[48] Is the use of cetuximab in the first-line treatment of recurrent/metastatic head and neck cancer still important?
Vitale, Pasquale
De Falco, Vincenzo
Addeo, Raffaele
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (07) : 481 - 484
[49] A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent/metastatic oral squamous cell carcinoma
Ju, Houyu
Wei, Dongliang
Wu, Yunteng
Liu, Yang
Ding, Qi
Rui, Mengyu
Fan, Zongyu
Yao, Yanli
Hu, Jingzhou
Ren, Guoxin
[J]. MEDCOMM, 2023, 4 (04):
[50] Essential news of current guidelines: head and neck squamous cell carcinoma
Fuereder, Thorsten
[J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 (04) : 278 - 281

← 1 2 3 4 5 →